Growth Metrics

Biogen (BIIB) Other Non-Current Assets (2016 - 2025)

Biogen (BIIB) has 17 years of Other Non-Current Assets data on record, last reported at $750.6 million in Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 33.92% year-over-year to $750.6 million; the TTM value through Dec 2025 reached $750.6 million, up 33.92%, while the annual FY2025 figure was $750.6 million, 33.92% up from the prior year.
  • Other Non-Current Assets reached $750.6 million in Q4 2025 per BIIB's latest filing, up from $729.7 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2.5 billion in Q2 2021 and bottomed at $559.1 million in Q1 2025.
  • Average Other Non-Current Assets over 5 years is $1.2 billion, with a median of $929.8 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: soared 114.31% in 2021, then crashed 53.21% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $1.9 billion in 2021, then fell by 21.15% to $1.5 billion in 2022, then plummeted by 51.28% to $745.0 million in 2023, then fell by 24.77% to $560.5 million in 2024, then surged by 33.92% to $750.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $750.6 million in Q4 2025, $729.7 million in Q3 2025, and $637.7 million in Q2 2025.